IASLC > International Association for the Study of Lung Cancer > Conferences & Events > Event Details
Women and Lung Cancer: Screening, Treatment and Beyond
August 29, 2019 | Online


This one hour program will feature 3 presentations and provide ample time for questions and discussion. Thiswebinar will discuss the global impact of lung cancer on women and the changinglandscape from past, current, and future. Recent analysis from multiple largelung cancer screening trials confirm the objective curative benefit of lungcancer screening and results suggest this benefit is considerately greater inwomen; the magnitude of these favorable outcomes far exceed the mortalitybenefit previously reported with breast or colon cancer screening. Low dose CTscreening especially integrated with comprehensive tobacco cessation is aremarkable potent tool for improving health of tobacco-exposed individuals butespecially impactful with women. Differences in gender will be discussedregarding lung cancer in never smokers, susceptibility to cigarette smoke, lungcancer development, and response to screening and treatment. Future directionsin lung cancer research and screening will be reviewed. 

Program Sponsors: 


What you should expect to learn

  • Understand the global burden of lung cancer in women and how it differs from males
  • Discuss the importance of lung cancer screening in the female population to detect lung cancer earlier when it's more easily treated with significant improved survival
  • Describe treatment for lung cancer in women and gender differences in response and survival
  • Provide an overview for future directions regarding lung cancer screening and research

James L. Mulshine, MD
Chair, Screening and Early Detection Committee, IASLC
Rush University, Chicago

Mary Pasquinelli, DNP, FNP-BC: Presenting: The Global Burden of Lung Cancer in Women, What Do we Know?
Adjunct Clinical Instructor - UIC College of Nursing
Director, Lung Cancer Screening Program
Advanced Practice Nurse, Pulmonary and Medical Oncology
University of Illinois Hospital & Health Science System (UI Health)

Claudia I. Henschke, PhD, MD: Presenting: Lung Screening for Women- Susceptibility and Cure Rates

Department of Radiology
Director, Early Lung and Cardiac Program
The Icahn School of Medicine at Mount Sinai
New York, NY  

Andrea S. Wolf, MD, MPH: Presenting: Treatment of Lung Cancer: Does Gender Matter?
Associate Professor
Director, New York Mesothelioma Program
Department of Thoracic Surgery
The Icahn School of Medicine at Mount Sinai
New York, NY